Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
- 24 April 2009
- journal article
- clinical trial
- Published by Wiley in European Journal of Haematology
- Vol. 58 (4) , 233-240
- https://doi.org/10.1111/j.1600-0609.1997.tb01660.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Leukemia in the Central Nervous SystemActa Medica Scandinavica, 2009
- Acute Leukemia in Middle Norway 1984-88Leukemia & Lymphoma, 1994
- Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapyJournal of Internal Medicine, 1992
- Short‐term remission induction and consolidation therapy for adult acute myelogenous leukemiaHematological Oncology, 1991
- Remission rate and survival in acute myeloid leukemia: Impact of selection and chemotherapyEuropean Journal of Haematology, 1991
- The frequency of long‐term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow‐up time of 6 yearsBritish Journal of Haematology, 1989
- Collection, manipulation and freezing of haemopoietic stem cellsClinics in Haematology, 1986
- A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaMedical and Pediatric Oncology, 1979
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958